CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$30.71
+0.49%Forward multiples
Based on analyst estimates
- P/E forward
- 99.67x
- P/E 2026E
- 256.95x
- P/E 2027E
- 88.20x
- P/E 2028E
- 60.29x
- P/S forward
- 7.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- 82.58x
- PEG TTM
- —
- Price / book
- 14.67x
- Price / sales
- 8.77x
- Price / cash flow
- 43.08x
Enterprise value
- Enterprise value
- $8.3B
- EV / sales
- 8.43x
- EV / EBITDA
- 48.28x
- EV / EBIT
- 54.40x
- Market cap
- $8.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026